Compounding Pharmacies Promise Savings. Sometimes They Deliver. Here's How to Tell the Difference.

If you've been anywhere near a GLP-1 medication conversation in the past two years — and honestly, who hasn't — you've probably seen the ads. Compounded semaglutide. Compounded tirzepatide. A fraction of the cost of Ozempic or Mounjaro. Get it shipped to your door.

The pitch is compelling. And it's not entirely wrong. Compounding pharmacies do, in certain situations, offer genuine cost advantages over their commercial counterparts. But the blanket claim that compounded medications are simply "cheaper and just as good" glosses over a set of financial and clinical realities that every patient deserves to understand before signing up.

What Compounding Actually Is

Compounding pharmacies create customized medications — mixing, combining, or altering drugs to meet specific patient needs that commercially available products don't address. A patient who's allergic to a dye used in a standard tablet. A child who needs a liquid version of a medication that only comes in pill form. Someone who requires a dose that no manufacturer produces.

This is the legitimate, time-honored purpose of compounding. It fills genuine gaps in the commercial drug supply.

What's newer — and more commercially aggressive — is the marketing of compounded drugs as a straight cost-saving alternative to brand-name medications that are widely available but expensive. The GLP-1 boom made this trend impossible to ignore: with Ozempic running over $900 per month without insurance, compounded semaglutide at $200-$300 started looking very attractive.

When Compounding Genuinely Saves Money

There are real scenarios where a compounding pharmacy is the smartest financial choice available.

Drug shortages. When the FDA places a commercially manufactured drug on its shortage list, compounding pharmacies are legally permitted to produce copies of that medication. During the extended GLP-1 shortage period, compounded semaglutide and tirzepatide were produced legally under this exemption — and for patients who couldn't access or afford the brand-name versions, they represented a legitimate alternative.

Hormone replacement therapy. Compounded bioidentical hormones are a well-established part of the HRT market. For patients who need customized doses or combinations that commercial products don't offer, compounding can be both medically appropriate and more affordable than piecing together multiple brand-name products.

Topical medications. Custom-compounded topical creams and gels — for pain management, dermatology, or wound care — sometimes offer cost advantages over commercial alternatives, particularly when a patient needs a specific concentration or combination.

Pediatric formulations. Children often need medications in doses or forms that manufacturers don't produce commercially. Compounding a liquid suspension or a smaller-dose formulation can be the only practical option, and typically costs less than off-label use of adult formulations.

When Compounding Costs More Than You'd Expect

Here's where the savings narrative breaks down.

Insurance almost never covers it. This is the single biggest financial reality that compounding pharmacy marketing tends to downplay. Commercially manufactured drugs — including many expensive brand-name medications — are covered by insurance, at least partially. Compounded drugs almost universally are not. That means the "low" price you're quoted is your full price, with no insurance offset.

For a patient with decent insurance coverage, a brand-name drug with a $50 copay may be significantly cheaper than a compounded alternative priced at $150 cash — even though the compounded version is technically the "lower cost" drug.

Quality and consistency aren't guaranteed. Commercial medications go through rigorous FDA manufacturing standards. Compounding pharmacies are regulated differently — some are registered with the FDA as outsourcing facilities (503B pharmacies) with stricter oversight, while others operate as traditional 503A compounding pharmacies with lighter regulation. The difference matters for potency, sterility, and consistency.

There have been documented cases of compounded medications being under- or over-dosed, contaminated, or otherwise inconsistent. That's not an argument against all compounding — but it is an argument for being selective about where you source compounded medications.

The GLP-1 window is closing. The FDA removed semaglutide and tirzepatide from the shortage list in 2024, which means the legal basis for widespread compounding of these specific drugs has narrowed significantly. Compounding pharmacies marketing these products as routine alternatives may be operating in legally gray territory. Patients who built their treatment plans around compounded GLP-1s may need to reassess.

How to Evaluate a Compounding Pharmacy's Cost Claims

If you're considering a compounded medication for cost reasons, here's a framework for evaluating whether the savings are real.

Step one: Get your actual insurance cost. Before comparing anything, find out exactly what your insurance would charge for the commercially available version of the drug — including whether prior authorization is required and what your realistic timeline looks like. GoodRx can also give you a cash-pay benchmark for comparison.

Step two: Check the FDA's 503B outsourcing facility registry. Pharmacies on this list are held to higher manufacturing standards. If a compounding pharmacy isn't on this list and is producing sterile injectables or other high-risk formulations, that's a significant red flag.

Step three: Ask about ingredients specifically. Some compounding pharmacies have used salt forms of active ingredients — like semaglutide sodium or semaglutide acetate — rather than the base compound used in FDA-approved drugs. The safety and equivalency of these variants hasn't been established. Ask explicitly what form of the active ingredient is being used.

Step four: Calculate total annual cost, not monthly cost. Compounding pharmacies often advertise monthly costs. Run the math across a full year, factor in any required telehealth consultations or subscription fees some compounding-adjacent services charge, and compare that to your annual cost for the commercial alternative.

The Bottom Line on Compounding

Compounding pharmacies aren't a scam. Many are legitimate, carefully run operations serving real patient needs. But they're also not a universal solution to high drug costs, and the marketing around them — particularly in the GLP-1 space — has gotten well ahead of what the evidence and the law actually support.

If a compounding pharmacy is offering you a significant cost savings and the drug in question is on the FDA shortage list, your insurance doesn't cover the commercial version at all, or you have a genuine clinical need for a custom formulation, the case for compounding can be solid.

If you're being told compounding is simply cheaper and better without any of those factors in play, it's worth asking a few more questions before you hand over your credit card.